These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treatment of chronic myeloleukosis with myelosan. PAVLOVSKAIA NI Klin Med (Mosk); 1958 Jul; 36(7):82-8. PubMed ID: 13576705 [No Abstract] [Full Text] [Related]
23. [1-4-Dimethanesulfoxybutane therapy of chronic leukemic myeloses]. PETRESCU M; PAPAZIAN R; OLARU C Med Interna (Bucur); 1957 May; 9(5):699-709. PubMed ID: 13482655 [No Abstract] [Full Text] [Related]
24. Method of treatment of chronic myeloleukosis with myelosan. MOKEEVA RA Klin Med (Mosk); 1958 Jul; 36(7):89-93. PubMed ID: 13576706 [No Abstract] [Full Text] [Related]
25. [Myelosan (1,4-dimethanesulfoniloxybutane) and its significance in the therapy of chronic myeloleukosis]. CHERNOV VA Klin Med (Mosk); 1958 Jul; 36(7):73-82. PubMed ID: 13576704 [No Abstract] [Full Text] [Related]
26. [Therapeutic considerations in chronic myeloid leukemia]. Hunstein W Med Klin; 1974 Mar; 69(10):412-6. PubMed ID: 4598268 [No Abstract] [Full Text] [Related]
27. Chronic myeloid leukemia: untreated for ten years. Hansen TM Dan Med Bull; 1972 May; 19(3):114-6. PubMed ID: 4502559 [No Abstract] [Full Text] [Related]
28. [Myleran in chronic myelogenic leukemia]. JOSEPHSEN JO Nord Med; 1956 Oct; 56(42):1530-1. PubMed ID: 13388118 [No Abstract] [Full Text] [Related]
29. [Observation of a child with leukemia for 10 years]. Tonkonog AP Probl Gematol Pereliv Krovi; 1967 Aug; 12(8):52-4. PubMed ID: 5260221 [No Abstract] [Full Text] [Related]
30. [Data on an unusual acute transformation in a case of chronic myeloid leukemia following dimethylsulfonoxy-butane therapy]. GIGANTE D Clin Ter; 1958 May; 14(5):469-85. PubMed ID: 13561522 [No Abstract] [Full Text] [Related]
31. Busulfan (1, 4-dimethanesulfonyloxybutane, myleran); summary of clinical results. GALTON DA; TILL M; WILTSHAW E Ann N Y Acad Sci; 1958 Apr; 68(3):967-73. PubMed ID: 13627743 [No Abstract] [Full Text] [Related]
32. [Treatment of chronic myeloid leukemia]. Tanzer J; Jacquillat C; Weil M; Briére J; Bussel A; Boiron M; Bernard J Rev Prat; 1973 Oct; 23(45):3997-8 passim. PubMed ID: 4522469 [No Abstract] [Full Text] [Related]
33. [Contribution to the study of the treatment of myeloid leukemia with misulban]. TEXIER G; VALLAT JN J Med Bord; 1956 Nov; 133(11):1148-53. PubMed ID: 13385608 [No Abstract] [Full Text] [Related]
34. Busulfan treatment of leukemia during pregnancy. A case report. Nolan GH; Marks R; Perez C Obstet Gynecol; 1971 Jul; 38(1):136-8. PubMed ID: 5284102 [No Abstract] [Full Text] [Related]
35. [Clinical effects of Vercyte(A-803) on chronic myelogenous leukemia]. Kinugasa K; Takaku F; Sasa S; Mizoguchi H; Komine M Naika; 1971; 28(1):151-6. PubMed ID: 5284419 [No Abstract] [Full Text] [Related]
36. Mitomycin C in the treatment of chronic myelogenous leukemia. Hoshino A Nagoya J Med Sci; 1967 Mar; 29(4):317-44. PubMed ID: 5234483 [No Abstract] [Full Text] [Related]
40. Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy. HAUT A; ABBOTT WS; WINTROBE MM; CARTWRIGHT GE Blood; 1961 Jan; 17():1-19. PubMed ID: 13712355 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]